October 18, 2007 - At TCT 2007, Radi Medical Systems Inc. focuses on the Femostop HD Femoral Compression System, that with the addition of a hemostatic dressing, promotes dual-action hemostasis, reportedly reducing the need for stocking multiple hemostasis products.
October 18, 2007 - Cordis Corp. will present clinical data backing the CYPHER Sirolimus-eluting coronary stent at the ...
October 18, 2007 - Abbott announced that trial results for ABSORB, the world’s first clinical trial evaluating the safety and performance of a fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease, are positive.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
October 18, 2007 - Possis Medical Inc. featured the newest and the most important advancements in its "Complete Solution for Thrombus" at TCT 2007, including the AngioJet Ultra Thrombectomy System, AngioJet Spiroflex and Spiroflex VG catheters and its Fetch Aspiration Catheter.
Ever since the BASKET-LATE study came out suggesting an increase in the rate of death and myocardial infarction in ...
October 17, 2007 - CryoCor, Inc., a medical device company focused on the treatment of cardiac arrhythmias, announced today that CryoCath Technologies Inc. has filed a lawsuit against CryoCor in the United States District Court for the District of Delaware alleging that CryoCor infringes several of CryoCath’s U.S. patents.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
The FLAIR Endovascular Stent Graft treats stenoses (narrowing) at the venous anastomosis of synthetic arteriovenous (AV) grafts in hemodialysis patients to increase blood flow.
October 17, 2007 - After a three-week trial, a jury rendered a verdict of "willful" patent infringement in a dispute filed against CHF Technologies, Inc., d/b/a BioVentrix, after Chase Medical sued BioVentrix alleging its Blue Egg Sizer, a hollow, blue silicone device used to guide surgeons in surgically resizing the heart, infringed patents held by Chase.
The Toshiba Aquilion CT line’s product platform design reportedly allows for all customers to benefit from Toshiba’s ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 17, 2007 — The first trial to test whether medicated, drug-eluting (dispensing), stents can benefit patients who ...
Agfa HealthCare’s DX-S reportedly fills the gap in the current range of Digital Radiography Solutions by providing a ...
October 17, 2007 – Siemens Medical Solutions today announced that it recently received FDA 510(k) clearance for a 1.5 ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The FDA gave ZOLL Medical Corp., a manufacturer of resuscitation devices and related software solutions, clearance to market and sell the ZOLL AED Pro with See-Thru CPR technology, which is designed to help minimize interruptions in CPR. ZOLL aims to comply with a key recommendation of the American Heart Association’s Guidelines for Advanced Cardiac Life Support.
October 17, 2007 - Compared to bare metal stents, in patients with acute myocardial infarction, sirolimus-eluting stent ...
Building on the foundation of GE Healthcare’s CT platform, the LightSpeed VCT XT is reportedly capable of capturing ...
October 17, 2007
